Difficulty: Medium
Average Score: 92%
Practice
At a single hypnotic dose, the pharmacokinetics of diazepam is characterized by
Correct answer
B
Rationale
In the context of pharmacology of CNS drugs, understanding the pharmacokinetics of diazepam is crucial for healthcare professionals. The correct answer, B) Slow elimination with marked redistribution, aligns with the characteristics of diazepam's pharmacokinetics at a single hypnotic dose.
Diazepam, a benzodiazepine, is known for its lipophilicity, which leads to its rapid distribution into tissues after administration. At a single hypnotic dose, diazepam undergoes slow elimination due to its high lipid solubility, extensive tissue distribution, and hepatic metabolism into active metabolites. This slow elimination phase is further influenced by the drug's high protein binding, leading to a prolonged half-life.
Moreover, diazepam exhibits marked redistribution within the body due to its lipophilic nature, which allows it to accumulate in tissues like the brain and adipose tissue. This redistribution contributes to the drug's prolonged effects and duration of action, making it a suitable choice for hypnotic purposes.
Analyzing the incorrect options:
A) Slow elimination and little redistribution: This option is incorrect as diazepam does exhibit marked redistribution due to its lipophilicity.
C) Rapid elimination and marked redistribution: This option is incorrect as diazepam undergoes slow elimination and not rapid elimination.
D) Ultra-rapid elimination: This option is incorrect as diazepam's elimination is slow due to factors like high lipid solubility and protein binding.
Educationally, understanding the pharmacokinetics of diazepam provides insights into its clinical effects, dosing regimens, and potential for drug interactions. Healthcare professionals must grasp these concepts to ensure safe and effective use of CNS drugs like diazepam in clinical practice.
Diazepam, a benzodiazepine, is known for its lipophilicity, which leads to its rapid distribution into tissues after administration. At a single hypnotic dose, diazepam undergoes slow elimination due to its high lipid solubility, extensive tissue distribution, and hepatic metabolism into active metabolites. This slow elimination phase is further influenced by the drug's high protein binding, leading to a prolonged half-life.
Moreover, diazepam exhibits marked redistribution within the body due to its lipophilic nature, which allows it to accumulate in tissues like the brain and adipose tissue. This redistribution contributes to the drug's prolonged effects and duration of action, making it a suitable choice for hypnotic purposes.
Analyzing the incorrect options:
A) Slow elimination and little redistribution: This option is incorrect as diazepam does exhibit marked redistribution due to its lipophilicity.
C) Rapid elimination and marked redistribution: This option is incorrect as diazepam undergoes slow elimination and not rapid elimination.
D) Ultra-rapid elimination: This option is incorrect as diazepam's elimination is slow due to factors like high lipid solubility and protein binding.
Educationally, understanding the pharmacokinetics of diazepam provides insights into its clinical effects, dosing regimens, and potential for drug interactions. Healthcare professionals must grasp these concepts to ensure safe and effective use of CNS drugs like diazepam in clinical practice.